Why choose our Emerging Companies and Venture Capital Lawyers?
We are experts in our field, supported by our focus sector groups in technology, financial services, healthcare and life sciences and by incentives, regulatory, commercial, IP, Privacy, tax and employment colleagues across our European network.
Our cross-practice teams help clients navigate complicated regulatory and commercial issues to get deals done, recruit and retain talent and protect and monetise their intellectual property and data assets.
In the technology sector, we act across the full TMT spectrum, from FinTech and AI to digital, VR, eCommerce and gaming. The high-growth tech companies we act for are leading innovators in their fields, who are able to rely on our responsive expert advice.
Our life sciences specialists advise cutting-edge genomics, biopharma, digital health and medical device companies from early stage spin-out and seed financing rounds through to development capital and Exit. We regularly work alongside our expert IP, patent and licensing/commercial colleagues who help support these fast-growth companies on all legal needs.
We act for leading investment funds (including EIS and VCT funds) on their deal flow and deployment of capital. We have expertise on all forms of venture financing, from SAFEs and Advanced Subscriptions, to convertible loan notes and priced equity rounds including secondary liquidity for founders and early investors.
Our venture debt practice acts for some of the best-known providers in the market while supporting our high-growth company clients on their venture debt facilities, security and subordination arrangements.
Subscribe Today!
Subscribe to the latest Corporate insights
Stay up to date with personalised email alerts with the latest insights from Fieldfisher's lawyers.
Subscribe now